📰 Blake Fallis News
Page 9 - Blake Fallis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Blake Fallis. Real-time updates on events, politics, business and more.
August 19, 2022
TORONTO, ON / ACCESSWIRE / August 19, 2022 / AI/ML Innovations Inc. (the "Company") (CSE:AIML; OTCQB: AIMLF; FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning
August 11, 2022
VICTORIA, BC / ACCESSWIRE / August 11, 2022 / Erin Ventures Inc. ("Erin" or the "Company") (TSXV:EV) and their partner Temas Resources Corp. (CSE:TMAS) are pleased to report the filing of an Independent
August 2, 2022
- Alakin to be utilized in a Parkinson study set to commence in Paris, France -TORONTO, ON / ACCESSWIRE / August 2, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed
July 19, 2022
- pre-commercial pilot study set to commence in 30,000-patient primary care facility in Paris -TORONTO, ON / ACCESSWIRE / July 19, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company
July 7, 2022
TORONTO, ON / ACCESSWIRE / July 7, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies
June 22, 2022
TORONTO, ON / ACCESSWIRE / June 22, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies
June 9, 2022
TORONTO, ON / ACCESSWIRE/ June 9, 2022 / AI/ML Innovations Inc. (CSE:AIML); (OTCQB:AIMLF); (FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies
May 4, 2022
TORONTO, ON / ACCESSWIRE / May 4, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that
March 28, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
March 28, 2022
- MedWatch to address needs in the $327 billion-dollar US diabetes market -- License includes annual payment to Health Gauge of US$120,000, 2% gross sales royalty, US$2Million termination fee, and other